These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 34042280)

  • 81. Mutations affecting both the rearranged and the unrearranged PML alleles in refractory acute promyelocytic leukaemia.
    Iaccarino L; Ottone T; Divona M; Cicconi L; Cairoli R; Voso MT; Lo-Coco F
    Br J Haematol; 2016 Mar; 172(6):909-13. PubMed ID: 26728337
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Identification and monitoring of atypical PML/RARA fusion transcripts in acute promyelocytic leukemia.
    Iaccarino L; Divona M; Ottone T; Cicconi L; Lavorgna S; Ciardi C; Alfonso V; Travaglini S; Facchini L; Cimino G; Di Bona E; Voso MT; Lo-Coco F
    Genes Chromosomes Cancer; 2019 Jan; 58(1):60-65. PubMed ID: 30421475
    [TBL] [Abstract][Full Text] [Related]  

  • 83. A PML/RARA chimeric gene on chromosome 12 in a patient with acute promyelocytic leukemia (M4) associated with a new variant translocation: t(12;15;17)(q24;q24;q11).
    Bennour A; Tabka I; Youssef YB; Zaier M; Hizem S; Khelif A; Saad A; Sennana H
    Med Oncol; 2013 Mar; 30(1):409. PubMed ID: 23292868
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Missense mutations in PML-RARA are critical for the lack of responsiveness to arsenic trioxide treatment.
    Goto E; Tomita A; Hayakawa F; Atsumi A; Kiyoi H; Naoe T
    Blood; 2011 Aug; 118(6):1600-9. PubMed ID: 21613260
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Acute myeloid leukemia with mutated NPM1 mimics acute promyelocytic leukemia presentation.
    Arana Rosainz MJ; Nguyen N; Wahed A; Lelenwa LC; Aakash N; Schaefer K; Rios A; Kanaan Z; Chen L
    Int J Lab Hematol; 2021 Apr; 43(2):218-226. PubMed ID: 33099879
    [TBL] [Abstract][Full Text] [Related]  

  • 86. No prognostic significance of normalized copy number of PML-RARA transcript at diagnosis in patients with acute promyelocytic leukemia.
    Rasekh EO; Elsayed GM; Fathy S
    Hematol Oncol Stem Cell Ther; 2021 Jun; 14(2):119-125. PubMed ID: 32735792
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Retinoic acid receptor alpha gene in t (15; 17) APL].
    Takashima T; Misawa S
    Nihon Rinsho; 1992 Jun; 50(6):1363-8. PubMed ID: 1325570
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Tetraploid acute promyelocytic leukemia with double t(15;17) and PML/RARA rearrangements detected by fluorescence in situ hybridization analysis.
    Oh SH; Park TS; Kim HH; Chang CL; Lee EY; Son HC; Chung JS; Cho GJ
    Cancer Genet Cytogenet; 2003 Aug; 145(1):49-53. PubMed ID: 12885462
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Fusion of retinoic acid receptor alpha to NuMA, the nuclear mitotic apparatus protein, by a variant translocation in acute promyelocytic leukaemia.
    Wells RA; Catzavelos C; Kamel-Reid S
    Nat Genet; 1997 Sep; 17(1):109-13. PubMed ID: 9288109
    [TBL] [Abstract][Full Text] [Related]  

  • 90. OBFC2A/RARA: a novel fusion gene in variant acute promyelocytic leukemia.
    Won D; Shin SY; Park CJ; Jang S; Chi HS; Lee KH; Lee JO; Seo EJ
    Blood; 2013 Feb; 121(8):1432-5. PubMed ID: 23287866
    [TBL] [Abstract][Full Text] [Related]  

  • 91. AML-1/ETO fusion protein is a dominant negative inhibitor of transcriptional repression by the promyelocytic leukemia zinc finger protein.
    Melnick A; Carlile GW; McConnell MJ; Polinger A; Hiebert SW; Licht JD
    Blood; 2000 Dec; 96(12):3939-47. PubMed ID: 11090081
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Report of IRF2BP1 as a novel partner of RARA in variant acute promyelocytic leukemia.
    Jiang M; Wang X; Yu M; Jiang S; Hong M; Zhou Y; Li F; Liu H; Zhang Z
    Am J Hematol; 2024 May; 99(5):1005-1007. PubMed ID: 38410879
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Eradication of acute promyelocytic leukemia-initiating cells by PML/RARA-targeting.
    Nasr R; de Thé H
    Int J Hematol; 2010 Jun; 91(5):742-7. PubMed ID: 20455087
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Specific expression of the annexin VIII gene in acute promyelocytic leukemia.
    Chang KS; Wang G; Freireich EJ; Daly M; Naylor SL; Trujillo JM; Stass SA
    Blood; 1992 Apr; 79(7):1802-10. PubMed ID: 1313714
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Aml1/ETO and Pml/RARA rearrangements in a case of AML-M2 acute myeloblastic leukemia with t(15;17).
    Varella-Garcia M; Brizard F; Roche J; Flandrin G; Drabkin H; Brizard A
    Leuk Lymphoma; 1999 Apr; 33(3-4):403-6. PubMed ID: 10221524
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Deletion of MYC and presence of double minutes with MYC amplification in a morphologic acute promyelocytic leukemia-like case lacking RARA rearrangement: could early exclusion of double-minute chromosomes be a prognostic factor?
    Frater JL; Hoover RG; Bernreuter K; Batanian JR
    Cancer Genet Cytogenet; 2006 Apr; 166(2):139-45. PubMed ID: 16631470
    [TBL] [Abstract][Full Text] [Related]  

  • 97. ZBTB16-RARα variant of acute promyelocytic leukemia with tuberculosis: a case report and review of literature.
    Palta A; Dhiman P; Cruz SD
    Korean J Hematol; 2012 Sep; 47(3):229-32. PubMed ID: 23071480
    [TBL] [Abstract][Full Text] [Related]  

  • 98. The PRKAR1A gene is fused to RARA in a new variant acute promyelocytic leukemia.
    Catalano A; Dawson MA; Somana K; Opat S; Schwarer A; Campbell LJ; Iland H
    Blood; 2007 Dec; 110(12):4073-6. PubMed ID: 17712046
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Evaluating frequency of PML-RARA mutations and conferring resistance to arsenic trioxide-based therapy in relapsed acute promyelocytic leukemia patients.
    Lou Y; Ma Y; Sun J; Ye X; Pan H; Wang Y; Qian W; Meng H; Mai W; He J; Tong H; Jin J
    Ann Hematol; 2015 Nov; 94(11):1829-37. PubMed ID: 26294332
    [TBL] [Abstract][Full Text] [Related]  

  • 100. [Effects of all-trans retinoic acid and arsenic trioxide on tissue factor expression of acute promyelocytic leukemia cells].
    Guo W; Wang H; Zhao W
    Zhonghua Yi Xue Za Zhi; 2000 May; 80(5):327-31. PubMed ID: 11798779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.